Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
197
datasets available to search
ShareScore release 0.7.1
Dataset results
197 results for “BCMA”
Anti-BCMA CAR-T Cell Therapy for the R/R Multiple Myeloma
ClinicalTrials.gov study NCT04637269. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells
ClinicalTrials.gov study NCT06277427. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluate CART-BCMA in Patients With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05346198. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Anti-BCMA CAR-NK Cell Therapy for the Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05008536. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of CS1-targeted CAR-T Cells Therapy for Relapsed Multiple Myeloma After BCMA CAR-T Cells Therapy
ClinicalTrials.gov study NCT04541368. IPD Sharing: NO. Countries: 1. Publications: 0.
An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases
ClinicalTrials.gov study NCT06503224. IPD Sharing: YES. Countries: 1. Publications: 0.
CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05950113. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of BCMA CAR-T Cell Therapy for Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT05712083. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose Exploration Study OF JWCAR129, BCMA-Targeted CART for RRMM
ClinicalTrials.gov study NCT04677452. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BCMA and CD19 Targeted Fast Dual CART for Chromosomal Abnomalities High-risk BCMA+ Multiple Myeloma
ClinicalTrials.gov study NCT04617704. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases
ClinicalTrials.gov study NCT07315087. IPD Sharing: NO. Countries: 1. Publications: 0.
Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma
ClinicalTrials.gov study NCT03448978. IPD Sharing: NO. Countries: 1. Publications: 0.
CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants
ClinicalTrials.gov study NCT07350837. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Research of BCMA-Targeted CAR-T in B Cell Malignancies
ClinicalTrials.gov study NCT02954445. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Primary Plasma Cell Leukemia
ClinicalTrials.gov study NCT07106684. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participa
ClinicalTrials.gov study NCT04923893. IPD Sharing: YES. Countries: 26. Publications: 0.
Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma
ClinicalTrials.gov study NCT06209606. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Changes in bone marrow tumor and immune cells correlate with durability of remissions following BCMA CAR T therapy in myeloma
GEO Series GSE210079. Homo sapiens. 24 samples. Type: Expression profiling by high throughput sequencing.
Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with Multiple Myeloma
GEO Series GSE143317. Homo sapiens. 2 samples. Type: Expression profiling by high throughput sequencing.
RNASeq: lenalidomide-treated anti-BCMA CAR T cells
GEO Series GSE113281. Homo sapiens. 23 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.